Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer
Takiuchi, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 459-463
2011
ISSN/ISBN: 0047-1852 PMID: 22214004 Document Number: 651443
Document emailed within 1 workday
Related Documents
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205Koukourakis, G.; Kouloulias, V.; Zacharias, G.; Koukourakis, M. 2010: Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy Journal of Buon: Official Journal of the Balkan Union of Oncology 15(4): 652-659
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Zhang, T.; Su, D.; Li, J.; Wang, Y.; Han, C.; Jiao, S.; Bai, L. 2015: Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma Zhonghua Wei Chang Wai Ke Za Zhi 18(6): 584-588
Kamnerdsupaphon, P.; Lorvidhaya, V.; Chitapanarux, I.; Tonusin, A.; Sukthomya, V. 2007: FOLFIRI chemotherapy for metastatic colorectal cancer patients Journal of the Medical Association of Thailand 90(10): 2121-2127
Muro, K. 2013: Team medicine in chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 435-439
Katsumoto, Y.; Aritake, N.; Endoh, A. 2010: The efficacy of cetuximab for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2523-2525
Maoleekoonpairoj, S. 1995: Combination 5-fluorouracil (5-FU) and alpha interferon (IFN) in metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 3): 285
Watanabe, T.; Sawada, T.; Kubota, Y.; Ooya, M.; Masaki, T.; Sameshima, S.; Shinozaki, M.; Tsuno, N.; Uchiyama, M.; Sakaguchi, M. 1992: Continuous intra-arterial infusion chemotherapy in colorectal cancer patients with nonresectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1515-1518
Sasaki, K.; Takasaka, H.; Nishikawa, N.; Yoshikawa, T.; Hirata, K. 2003: Home chemotherapy and outpatient treatment for metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 7): 333-337
Conroy, T.; Marchal, F.; Briançon, S. 2000: Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer New England Journal of Medicine 342(20): 1525; Author Reply 1526-1527
Iwasa, S.; Shimada, Y. 2011: Treatment strategy of chemotherapy for unresectable metastatic or recurrent colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 427-432
Peking, A.; Marinov, V. 1989: The immunoscintigraphic diagnosis of the metastases of colorectal cancer by using monoclonal antibodies Khirurgiia 42(6): 19-23
Jakovljevic, M.; Gutzwiller, F.; Schwenkglenks, M.; Milovanovic, O.; Rancic, N.; Varjacic, M.; Stojadinovic, D.; Dagovic, A.; Matter-Walstra, K. 2014: Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 1111-1120
Ide, Y.; Mikami, K.; Murata, K. 2009: Intermittent hepatic arterial infusion with systemic chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2172-2174
Burz, C.; Berindan-Neagoe, I.; Balacescu, O.; Todor, N.; Pelau, D.; Floares, C.; Kacso, G.; Tanaselia, C.; Ursu, M.; Vlase, L.; Leucuta, S.E.; Cristea, V.; Irimie, A. 2010: Oxaliplatin in patients with metastatic colorectal cancer: efficacy and pharmacokinetics parameters Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 263-269
Tsujie, M.; Fujiwara, S.; Kida, H.; Hayashi, N.; Fukuchi, S.; Yoshida, T.; Ebisui, C.; Sakita, I.; Hasuike, Y.; Fujimoto, T. 2005: A case of metastatic colon cancer treated with oxaliplatin combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1774-1775
Li, J.; Xu, J-Ming.; Li, J.; Zhang, X-Dong.; Bai, Y.; Chu, Y-Ping.; Wang, Y-Hua.; Liu, D-Qi.; Jin, M-Lin.; Shen, L. 2008: Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer Zhonghua Zhong Liu Za Zhi 30(3): 225-227
Vogel, C.L. 1995: Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review Seminars in Oncology 22(2 Suppl 5: 61-65
Umsawasdi, T.; Nilprabhassorn, P. 1978: Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer Journal of the Medical Association of Thailand 61(3): 158-161